speb/financial-data huggingface dataset:
CSCI.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -365000.00
CSCI.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -15000.00
CSCI.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 115000.00
CSCI.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 5000.00
CSCI.TO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 4000.00
CSCI.TO cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 8000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Net PPE: 9806000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 9806000.00
CSCI.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -462000.00
CSCI.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 193000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 3842000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 3842000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 1058000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 1058000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 1058000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 1058000.00
CSCI.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: -8859000.00
CSCI.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -2047000.00
CSCI.TO income_statement (annual, 2025-12-31) — Normalized Income: -10244950.00
CSCI.TO income_statement (quarterly, 2025-12-31) — Normalized Income: -2348750.00
CSCI.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: -8473000.00
CSCI.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -1470000.00
CSCI.TO cash_flow (annual, 2025-12-31) — Operating Gains Losses: 45000.00
CSCI.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -107000.00
CSCI.TO income_statement (annual, 2025-12-31) — Operating Income: -10365000.00
CSCI.TO income_statement (quarterly, 2025-12-31) — Operating Income: -2388000.00
CSCI.TO income_statement (annual, 2025-12-31) — Operating Revenue: 7498000.00
CSCI.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 1766000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 1061110.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 1061110.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Other Current Assets: 184000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 184000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 1124000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 1124000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -2444000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -2444000.00
CSCI.TO income_statement (annual, 2025-12-31) — Other Gand A: 4828000.00
CSCI.TO income_statement (quarterly, 2025-12-31) — Other Gand A: -2836000.00
CSCI.TO income_statement (annual, 2025-12-31) — Other Income Expense: -98000.00
CSCI.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: 210000.00
CSCI.TO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 46000.00
CSCI.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -6000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 125000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 125000.00
CSCI.TO income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 35000.00
CSCI.TO income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 15000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Other Properties: 10482000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 10482000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Other Receivables: 109000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Other Receivables: 109000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Payables: 854000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Payables: 854000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 1534000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 1534000.00
CSCI.TO cash_flow (annual, 2025-12-31) — Pension And Employee Benefit Expense: 436000.00
CSCI.TO cash_flow (quarterly, 2025-12-31) — Pension And Employee Benefit Expense: 122000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 471000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 471000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Prepaid Assets: 1404000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 1404000.00
CSCI.TO income_statement (annual, 2025-12-31) — Pretax Income: -10348000.00
CSCI.TO income_statement (quarterly, 2025-12-31) — Pretax Income: -2173000.00
CSCI.TO cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: -42000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Properties: 0.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CSCI.TO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -706000.00
CSCI.TO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -46000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Raw Materials: 585000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Raw Materials: 585000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Receivables: 1261000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 1261000.00
CSCI.TO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 4851000.00
CSCI.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1157000.00
CSCI.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 1188000.00
CSCI.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 289000.00
CSCI.TO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -365000.00
CSCI.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -15000.00
CSCI.TO income_statement (annual, 2025-12-31) — Research And Development: 2950000.00
CSCI.TO income_statement (quarterly, 2025-12-31) — Research And Development: 599000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: -20508000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -20508000.00
CSCI.TO income_statement (annual, 2025-12-31) — Salaries And Wages: 4272000.00
CSCI.TO cash_flow (annual, 2025-12-31) — Sale Of Business: 0.00
CSCI.TO cash_flow (quarterly, 2025-12-31) — Sale Of Business: 0.00
CSCI.TO cash_flow (annual, 2025-12-31) — Sale Of PPE: 244000.00
CSCI.TO cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 239000.00
CSCI.TO income_statement (annual, 2025-12-31) — Selling General And Administration: 10062000.00
CSCI.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 2398000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Share Issued: 1061110.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 1061110.00
CSCI.TO income_statement (annual, 2025-12-31) — Special Income Charges: -316000.00
CSCI.TO income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
CSCI.TO cash_flow (annual, 2025-12-31) — Stock Based Compensation: -12000.00
CSCI.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 88000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 3842000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 3842000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 3842000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 3842000.00
CSCI.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -19950.00
CSCI.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 29250.00
CSCI.TO income_statement (annual, 2025-12-31) — Tax Provision: 10000.00
CSCI.TO income_statement (quarterly, 2025-12-31) — Tax Provision: 10000.00
CSCI.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.15
CSCI.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.15
CSCI.TO balance_sheet (annual, 2025-12-31) — Taxes Receivable: 71000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 71000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Total Assets: 21431000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 21431000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 3842000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 3842000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Total Debt: 2149000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 2149000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 3842000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 3842000.00
CSCI.TO income_statement (annual, 2025-12-31) — Total Expenses: 17863000.00
CSCI.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 4154000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 17589000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 17589000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 9931000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 9931000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 13976000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 13976000.00
CSCI.TO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -10681000.00
CSCI.TO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -2388000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Total Tax Payable: 109000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 109000.00
CSCI.TO income_statement (annual, 2025-12-31) — Total Unusual Items: -133000.00
CSCI.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: 195000.00
CSCI.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -133000.00
CSCI.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 195000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Work In Process: 620000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Work In Process: 620000.00
CSCI.TO balance_sheet (annual, 2025-12-31) — Working Capital: 7887000.00
CSCI.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: 7887000.00
CSCI.TO income_statement (annual, 2025-12-31) — Write Off: 76000.00
CSCI.TO income_statement (quarterly, 2025-12-31) — Write Off: 0.00
CSCI.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 1523000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 1888000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 594000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1994000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -10359000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 4171000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 36000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 1046991.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Basic EPS: 10.26
CSCI.TO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 7307000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 3576000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -2000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 2023000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 22625000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 5005000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 5005000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -82000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -23000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -2177000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Change In Inventory: 135000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -296000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -415000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 166000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: -1009000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -1419000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -1009000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: -2282000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 22625000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 15319000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1095000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 289000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 9393000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 186000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 186000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1685000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 341000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 341000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 1237939.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: 8.70
CSCI.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 10757000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — EBIT: -137000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — EBITDA: 204000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -20000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 0.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 5005000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -82000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Finished Goods: 233000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -2179000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: -554000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of Business: -11293000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 8000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 565000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -1726000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 19603000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Gross Profit: 793000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 4000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 46000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 46000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Interest Income: 20000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 20000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Inventory: 1099000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 15319000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -23000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Leases: 5851000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 1837000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1837000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -82000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 112000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -30000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Net Income: 10757000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 10757000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -183000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Net Income Discontinuous Operations: 10940000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 10757000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -183000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 10757000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 10757000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: -26000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -82000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -82000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -26000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 9244000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 7000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 15317000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 0.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 0.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 131000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -361000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Normalized Income: -748000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -2177000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -11839000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Operating Income: -730000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 1888000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 3184159.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1259000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 569000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -1726000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: 573000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -18000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 71000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 8000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Other Properties: 10064000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Payables: 598000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 887000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Pension And Employee Benefit Expense: 0.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 43000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Pretax Income: -183000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -30000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -2000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Raw Materials: 490000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 1994000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1095000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 341000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -82000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Research And Development: 176000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -9751000.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 9000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 1347000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 3184159.00
CSCI.TO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 1000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 15319000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 15317000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Tax Provision: 0.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 18841000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 15319000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 2023000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 15319000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 2618000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 3522000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 9448000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1837000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -730000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 4000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items: 565000.00
CSCI.TO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 565000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Work In Process: 376000.00
CSCI.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: 7708000.00
CSCO balance_sheet (annual, 2021-07-31) — Net Debt: 2351000000.00
CSCO cash_flow (annual, 2021-07-31) — Sale Of Business: 194000000.00
CSCO cash_flow (annual, 2021-07-31) — Sale Of PPE: 28000000.00
CSCO income_statement (annual, 2022-07-31) — +Operating Expense: 18273000000.00
CSCO income_statement (annual, 2022-07-31) — +Total Revenue: 51557000000.00
CSCO balance_sheet (annual, 2022-07-31) — Accounts Payable: 2281000000.00
CSCO balance_sheet (annual, 2022-07-31) — Accounts Receivable: 6622000000.00
CSCO balance_sheet (annual, 2022-07-31) — Accumulated Depreciation: -8168000000.00
CSCO balance_sheet (annual, 2022-07-31) — Allowance For Doubtful Accounts Receivable: -83000000.00
CSCO income_statement (annual, 2022-07-31) — Amortization: 313000000.00
CSCO income_statement (annual, 2022-07-31) — Amortization Of Intangibles Income Statement: 313000000.00
CSCO income_statement (annual, 2022-07-31) — Basic Average Shares: 4170000000.00
CSCO income_statement (annual, 2022-07-31) — Basic EPS: 2.83
CSCO cash_flow (annual, 2022-07-31) — Beginning Cash Position: 9942000000.00
CSCO cash_flow (annual, 2022-07-31) — Capital Expenditure: -477000000.00
CSCO balance_sheet (annual, 2022-07-31) — Capital Stock: 42714000000.00
CSCO balance_sheet (annual, 2022-07-31) — Cash And Cash Equivalents: 7079000000.00
CSCO balance_sheet (annual, 2022-07-31) — Cash Cash Equivalents And Short Term Investments: 19267000000.00
CSCO cash_flow (annual, 2022-07-31) — Cash Dividends Paid: -6224000000.00
CSCO cash_flow (annual, 2022-07-31) — Cash Flow From Continuing Financing Activities: -15962000000.00
CSCO cash_flow (annual, 2022-07-31) — Cash Flow From Continuing Investing Activities: 1553000000.00
CSCO cash_flow (annual, 2022-07-31) — Cash Flow From Continuing Operating Activities: 13226000000.00
CSCO cash_flow (annual, 2022-07-31) — Change In Account Payable: -55000000.00
CSCO cash_flow (annual, 2022-07-31) — Change In Accrued Expense: -427000000.00
CSCO cash_flow (annual, 2022-07-31) — Change In Inventory: -1030000000.00
CSCO cash_flow (annual, 2022-07-31) — Change In Other Current Assets: -1615000000.00
CSCO cash_flow (annual, 2022-07-31) — Change In Other Current Liabilities: 535000000.00
CSCO cash_flow (annual, 2022-07-31) — Change In Other Working Capital: 638000000.00
CSCO cash_flow (annual, 2022-07-31) — Change In Payable: -55000000.00
CSCO cash_flow (annual, 2022-07-31) — Change In Payables And Accrued Expense: -482000000.00
CSCO cash_flow (annual, 2022-07-31) — Change In Receivables: 232000000.00
CSCO cash_flow (annual, 2022-07-31) — Change In Working Capital: -1722000000.00
CSCO cash_flow (annual, 2022-07-31) — Changes In Account Receivables: -1009000000.00
CSCO cash_flow (annual, 2022-07-31) — Changes In Cash: -1183000000.00
CSCO balance_sheet (annual, 2022-07-31) — Commercial Paper: 600000000.00
CSCO balance_sheet (annual, 2022-07-31) — Common Stock: 42714000000.00
CSCO cash_flow (annual, 2022-07-31) — Common Stock Dividend Paid: -6224000000.00
CSCO balance_sheet (annual, 2022-07-31) — Common Stock Equity: 39773000000.00
CSCO cash_flow (annual, 2022-07-31) — Common Stock Issuance: 660000000.00
CSCO cash_flow (annual, 2022-07-31) — Common Stock Payments: -8381000000.00
CSCO income_statement (annual, 2022-07-31) — Cost Of Revenue: 19309000000.00
CSCO balance_sheet (annual, 2022-07-31) — Current Assets: 36717000000.00
CSCO balance_sheet (annual, 2022-07-31) — Current Debt: 1099000000.00
CSCO balance_sheet (annual, 2022-07-31) — Current Debt And Capital Lease Obligation: 1099000000.00
CSCO balance_sheet (annual, 2022-07-31) — Current Deferred Liabilities: 12784000000.00
CSCO balance_sheet (annual, 2022-07-31) — Current Deferred Revenue: 12784000000.00
CSCO balance_sheet (annual, 2022-07-31) — Current Liabilities: 25640000000.00
CSCO cash_flow (annual, 2022-07-31) — Deferred Income Tax: -309000000.00
CSCO cash_flow (annual, 2022-07-31) — Deferred Tax: -309000000.00
CSCO cash_flow (annual, 2022-07-31) — Depreciation: 1957000000.00
CSCO cash_flow (annual, 2022-07-31) — Depreciation Amortization Depletion: 1957000000.00
CSCO income_statement (annual, 2022-07-31) — Depreciation Amortization Depletion Income Statement: 313000000.00
CSCO cash_flow (annual, 2022-07-31) — Depreciation And Amortization: 1957000000.00
CSCO income_statement (annual, 2022-07-31) — Depreciation And Amortization In Income Statement: 313000000.00
CSCO income_statement (annual, 2022-07-31) — Diluted Average Shares: 4192000000.00
CSCO income_statement (annual, 2022-07-31) — Diluted EPS: 2.82
CSCO income_statement (annual, 2022-07-31) — Diluted NI Availto Com Stockholders: 11812000000.00
CSCO income_statement (annual, 2022-07-31) — EBIT: 14837000000.00
CSCO income_statement (annual, 2022-07-31) — EBITDA: 16794000000.00
CSCO cash_flow (annual, 2022-07-31) — Effect Of Exchange Rate Changes: -180000000.00
CSCO cash_flow (annual, 2022-07-31) — End Cash Position: 8579000000.00
CSCO cash_flow (annual, 2022-07-31) — Financing Cash Flow: -15962000000.00
CSCO balance_sheet (annual, 2022-07-31) — Finished Goods: 717000000.00
CSCO cash_flow (annual, 2022-07-31) — Free Cash Flow: 12749000000.00
CSCO cash_flow (annual, 2022-07-31) — Gain Loss On Sale Of Business: -453000000.00
CSCO income_statement (annual, 2022-07-31) — Gain On Sale Of Security: 457000000.00
CSCO balance_sheet (annual, 2022-07-31) — Gains Losses Not Affecting Retained Earnings: -1622000000.00
CSCO income_statement (annual, 2022-07-31) — General And Administrative Expense: 2101000000.00
CSCO balance_sheet (annual, 2022-07-31) — Goodwill: 38304000000.00
CSCO balance_sheet (annual, 2022-07-31) — Goodwill And Other Intangible Assets: 40873000000.00
CSCO balance_sheet (annual, 2022-07-31) — Gross Accounts Receivable: 6705000000.00
CSCO balance_sheet (annual, 2022-07-31) — Gross PPE: 10165000000.00
CSCO income_statement (annual, 2022-07-31) — Gross Profit: 32248000000.00
CSCO cash_flow (annual, 2022-07-31) — Income Tax Paid Supplemental Data: 3663000000.00
CSCO balance_sheet (annual, 2022-07-31) — Income Tax Payable: 961000000.00
CSCO income_statement (annual, 2022-07-31) — Interest Expense: 360000000.00
CSCO income_statement (annual, 2022-07-31) — Interest Expense Non Operating: 360000000.00
CSCO income_statement (annual, 2022-07-31) — Interest Income: 476000000.00
CSCO income_statement (annual, 2022-07-31) — Interest Income Non Operating: 476000000.00
CSCO cash_flow (annual, 2022-07-31) — Interest Paid Supplemental Data: 355000000.00
CSCO balance_sheet (annual, 2022-07-31) — Inventory: 2568000000.00
CSCO balance_sheet (annual, 2022-07-31) — Invested Capital: 49288000000.00
CSCO cash_flow (annual, 2022-07-31) — Investing Cash Flow: 1553000000.00
CSCO cash_flow (annual, 2022-07-31) — Issuance Of Capital Stock: 660000000.00
CSCO cash_flow (annual, 2022-07-31) — Issuance Of Debt: 1049000000.00
CSCO balance_sheet (annual, 2022-07-31) — Loans Receivable: 2176000000.00
CSCO balance_sheet (annual, 2022-07-31) — Long Term Debt: 8416000000.00
CSCO balance_sheet (annual, 2022-07-31) — Long Term Debt And Capital Lease Obligation: 8416000000.00
CSCO cash_flow (annual, 2022-07-31) — Long Term Debt Issuance: 1049000000.00
CSCO cash_flow (annual, 2022-07-31) — Long Term Debt Payments: -3550000000.00
CSCO balance_sheet (annual, 2022-07-31) — Machinery Furniture Equipment: 1114000000.00
CSCO cash_flow (annual, 2022-07-31) — Net Business Purchase And Sale: -373000000.00
CSCO cash_flow (annual, 2022-07-31) — Net Common Stock Issuance: -7721000000.00
CSCO balance_sheet (annual, 2022-07-31) — Net Debt: 2436000000.00
CSCO income_statement (annual, 2022-07-31) — Net Income: 11812000000.00
CSCO income_statement (annual, 2022-07-31) — Net Income Common Stockholders: 11812000000.00
CSCO income_statement (annual, 2022-07-31) — Net Income Continuous Operations: 11812000000.00
CSCO income_statement (annual, 2022-07-31) — Net Income From Continuing And Discontinued Operation: 11812000000.00
CSCO income_statement (annual, 2022-07-31) — Net Income From Continuing Operation Net Minority Interest: 11812000000.00
CSCO cash_flow (annual, 2022-07-31) — Net Income From Continuing Operations: 11812000000.00
CSCO income_statement (annual, 2022-07-31) — Net Income Including Noncontrolling Interests: 11812000000.00
CSCO income_statement (annual, 2022-07-31) — Net Interest Income: 116000000.00
CSCO cash_flow (annual, 2022-07-31) — Net Investment Purchase And Sale: 2327000000.00
CSCO cash_flow (annual, 2022-07-31) — Net Issuance Payments Of Debt: -1895000000.00
CSCO cash_flow (annual, 2022-07-31) — Net Long Term Debt Issuance: -2501000000.00
CSCO income_statement (annual, 2022-07-31) — Net Non Operating Interest Income Expense: 116000000.00
CSCO cash_flow (annual, 2022-07-31) — Net Other Financing Charges: -122000000.00
CSCO cash_flow (annual, 2022-07-31) — Net Other Investing Changes: 76000000.00
CSCO balance_sheet (annual, 2022-07-31) — Net PPE: 1997000000.00
CSCO cash_flow (annual, 2022-07-31) — Net PPE Purchase And Sale: -477000000.00
CSCO cash_flow (annual, 2022-07-31) — Net Short Term Debt Issuance: 606000000.00
CSCO balance_sheet (annual, 2022-07-31) — Net Tangible Assets: -1100000000.00
CSCO balance_sheet (annual, 2022-07-31) — Non Current Accounts Receivable: 4009000000.00
CSCO balance_sheet (annual, 2022-07-31) — Non Current Deferred Assets: 4449000000.00
CSCO balance_sheet (annual, 2022-07-31) — Non Current Deferred Liabilities: 10480000000.00
CSCO balance_sheet (annual, 2022-07-31) — Non Current Deferred Revenue: 10480000000.00
CSCO balance_sheet (annual, 2022-07-31) — Non Current Deferred Taxes Assets: 4449000000.00
CSCO balance_sheet (annual, 2022-07-31) — Non Current Note Receivables: 2380000000.00
CSCO income_statement (annual, 2022-07-31) — Normalized EBITDA: 16343000000.00
CSCO income_statement (annual, 2022-07-31) — Normalized Income: 11443984000.00
CSCO cash_flow (annual, 2022-07-31) — Operating Cash Flow: 13226000000.00
CSCO cash_flow (annual, 2022-07-31) — Operating Gains Losses: -453000000.00
CSCO income_statement (annual, 2022-07-31) — Operating Income: 13975000000.00
CSCO income_statement (annual, 2022-07-31) — Operating Revenue: 51557000000.00
CSCO balance_sheet (annual, 2022-07-31) — Ordinary Shares Number: 4110000000.00
CSCO balance_sheet (annual, 2022-07-31) — Other Current Assets: 4355000000.00
CSCO balance_sheet (annual, 2022-07-31) — Other Current Borrowings: 499000000.00
CSCO balance_sheet (annual, 2022-07-31) — Other Current Liabilities: 5199000000.00
CSCO balance_sheet (annual, 2022-07-31) — Other Equity Adjustments: -1622000000.00
CSCO income_statement (annual, 2022-07-31) — Other Gand A: 2101000000.00
CSCO income_statement (annual, 2022-07-31) — Other Income Expense: 386000000.00
CSCO balance_sheet (annual, 2022-07-31) — Other Intangible Assets: 2569000000.00
CSCO balance_sheet (annual, 2022-07-31) — Other Inventories: 10000000.00
CSCO balance_sheet (annual, 2022-07-31) — Other Non Current Assets: 5957000000.00
CSCO balance_sheet (annual, 2022-07-31) — Other Non Current Liabilities: 1968000000.00
CSCO income_statement (annual, 2022-07-31) — Other Non Operating Income Expenses: -65000000.00
CSCO balance_sheet (annual, 2022-07-31) — Other Properties: 4832000000.00
CSCO balance_sheet (annual, 2022-07-31) — Other Receivables: 3905000000.00
CSCO balance_sheet (annual, 2022-07-31) — Other Short Term Investments: 12188000000.00
CSCO balance_sheet (annual, 2022-07-31) — Payables: 3242000000.00
CSCO balance_sheet (annual, 2022-07-31) — Payables And Accrued Expenses: 3242000000.00
CSCO balance_sheet (annual, 2022-07-31) — Pensionand Other Post Retirement Benefit Plans Current: 3316000000.00
CSCO balance_sheet (annual, 2022-07-31) — Preferred Stock: 0.00
CSCO income_statement (annual, 2022-07-31) — Pretax Income: 14477000000.00
CSCO balance_sheet (annual, 2022-07-31) — Properties: 4219000000.00
CSCO cash_flow (annual, 2022-07-31) — Provisionand Write Offof Assets: 55000000.00
CSCO cash_flow (annual, 2022-07-31) — Purchase Of Business: -373000000.00
CSCO cash_flow (annual, 2022-07-31) — Purchase Of Investment: -6256000000.00
CSCO cash_flow (annual, 2022-07-31) — Purchase Of PPE: -477000000.00
CSCO balance_sheet (annual, 2022-07-31) — Raw Materials: 1691000000.00
CSCO balance_sheet (annual, 2022-07-31) — Receivables: 10527000000.00
CSCO income_statement (annual, 2022-07-31) — Reconciled Cost Of Revenue: 17665000000.00
CSCO income_statement (annual, 2022-07-31) — Reconciled Depreciation: 1957000000.00
CSCO cash_flow (annual, 2022-07-31) — Repayment Of Debt: -3550000000.00
CSCO cash_flow (annual, 2022-07-31) — Repurchase Of Capital Stock: -8381000000.00
CSCO income_statement (annual, 2022-07-31) — Research And Development: 6774000000.00
CSCO income_statement (annual, 2022-07-31) — Restructuring And Mergern Acquisition: 6000000.00
CSCO balance_sheet (annual, 2022-07-31) — Retained Earnings: -1319000000.00
CSCO cash_flow (annual, 2022-07-31) — Sale Of Investment: 8583000000.00
CSCO cash_flow (annual, 2022-07-31) — Sale Of PPE: 91000000.00
CSCO income_statement (annual, 2022-07-31) — Selling And Marketing Expense: 9085000000.00
CSCO income_statement (annual, 2022-07-31) — Selling General And Administration: 11186000000.00
CSCO balance_sheet (annual, 2022-07-31) — Share Issued: 4110000000.00
CSCO income_statement (annual, 2022-07-31) — Special Income Charges: -6000000.00
CSCO cash_flow (annual, 2022-07-31) — Stock Based Compensation: 1886000000.00
CSCO balance_sheet (annual, 2022-07-31) — Stockholders Equity: 39773000000.00
CSCO balance_sheet (annual, 2022-07-31) — Tangible Book Value: -1100000000.00
CSCO income_statement (annual, 2022-07-31) — Tax Effect Of Unusual Items: 82984000.00
CSCO income_statement (annual, 2022-07-31) — Tax Provision: 2665000000.00
CSCO income_statement (annual, 2022-07-31) — Tax Rate For Calcs: 0.18
CSCO balance_sheet (annual, 2022-07-31) — Total Assets: 94002000000.00
CSCO balance_sheet (annual, 2022-07-31) — Total Capitalization: 48189000000.00
CSCO balance_sheet (annual, 2022-07-31) — Total Debt: 9515000000.00
CSCO balance_sheet (annual, 2022-07-31) — Total Equity Gross Minority Interest: 39773000000.00
CSCO income_statement (annual, 2022-07-31) — Total Expenses: 37582000000.00
CSCO balance_sheet (annual, 2022-07-31) — Total Liabilities Net Minority Interest: 54229000000.00
CSCO balance_sheet (annual, 2022-07-31) — Total Non Current Assets: 57285000000.00
CSCO balance_sheet (annual, 2022-07-31) — Total Non Current Liabilities Net Minority Interest: 28589000000.00
CSCO income_statement (annual, 2022-07-31) — Total Operating Income As Reported: 13969000000.00
CSCO balance_sheet (annual, 2022-07-31) — Total Tax Payable: 961000000.00
CSCO income_statement (annual, 2022-07-31) — Total Unusual Items: 451000000.00
CSCO income_statement (annual, 2022-07-31) — Total Unusual Items Excluding Goodwill: 451000000.00
CSCO balance_sheet (annual, 2022-07-31) — Tradeand Other Payables Non Current: 7725000000.00
CSCO balance_sheet (annual, 2022-07-31) — Work In Process: 150000000.00
CSCO balance_sheet (annual, 2022-07-31) — Working Capital: 11077000000.00
CSCO income_statement (annual, 2023-07-31) — +Operating Expense: 20191000000.00
CSCO income_statement (annual, 2023-07-31) — +Total Revenue: 56998000000.00
CSCO balance_sheet (annual, 2023-07-31) — Accounts Payable: 2313000000.00
CSCO balance_sheet (annual, 2023-07-31) — Accounts Receivable: 5854000000.00
CSCO balance_sheet (annual, 2023-07-31) — Accumulated Depreciation: -7973000000.00
CSCO balance_sheet (annual, 2023-07-31) — Allowance For Doubtful Accounts Receivable: -85000000.00
CSCO income_statement (annual, 2023-07-31) — Amortization: 282000000.00
CSCO income_statement (annual, 2023-07-31) — Amortization Of Intangibles Income Statement: 282000000.00
CSCO income_statement (annual, 2023-07-31) — Basic Average Shares: 4093000000.00
CSCO income_statement (annual, 2023-07-31) — Basic EPS: 3.08
CSCO cash_flow (annual, 2023-07-31) — Beginning Cash Position: 8579000000.00
CSCO cash_flow (annual, 2023-07-31) — Capital Expenditure: -849000000.00
CSCO balance_sheet (annual, 2023-07-31) — Capital Stock: 44289000000.00
CSCO balance_sheet (annual, 2023-07-31) — Cash And Cash Equivalents: 10123000000.00
CSCO balance_sheet (annual, 2023-07-31) — Cash Cash Equivalents And Short Term Investments: 26146000000.00
CSCO cash_flow (annual, 2023-07-31) — Cash Dividends Paid: -6302000000.00
CSCO cash_flow (annual, 2023-07-31) — Cash Flow From Continuing Financing Activities: -11626000000.00
CSCO cash_flow (annual, 2023-07-31) — Cash Flow From Continuing Investing Activities: -5107000000.00
CSCO cash_flow (annual, 2023-07-31) — Cash Flow From Continuing Operating Activities: 19886000000.00
CSCO cash_flow (annual, 2023-07-31) — Change In Account Payable: 27000000.00
CSCO cash_flow (annual, 2023-07-31) — Change In Accrued Expense: 651000000.00
CSCO cash_flow (annual, 2023-07-31) — Change In Inventory: -1069000000.00
CSCO cash_flow (annual, 2023-07-31) — Change In Other Current Assets: 5000000.00
CSCO cash_flow (annual, 2023-07-31) — Change In Other Current Liabilities: 48000000.00
CSCO cash_flow (annual, 2023-07-31) — Change In Other Working Capital: 3544000000.00
CSCO cash_flow (annual, 2023-07-31) — Change In Payable: 27000000.00
CSCO cash_flow (annual, 2023-07-31) — Change In Payables And Accrued Expense: 678000000.00
CSCO cash_flow (annual, 2023-07-31) — Change In Receivables: 1836000000.00
CSCO cash_flow (annual, 2023-07-31) — Change In Working Capital: 5042000000.00
CSCO cash_flow (annual, 2023-07-31) — Changes In Account Receivables: 734000000.00
CSCO cash_flow (annual, 2023-07-31) — Changes In Cash: 3153000000.00
CSCO balance_sheet (annual, 2023-07-31) — Commercial Paper: 0.00
CSCO balance_sheet (annual, 2023-07-31) — Common Stock: 44289000000.00
CSCO cash_flow (annual, 2023-07-31) — Common Stock Dividend Paid: -6302000000.00
CSCO balance_sheet (annual, 2023-07-31) — Common Stock Equity: 44353000000.00
CSCO cash_flow (annual, 2023-07-31) — Common Stock Issuance: 700000000.00
CSCO cash_flow (annual, 2023-07-31) — Common Stock Payments: -4890000000.00
CSCO income_statement (annual, 2023-07-31) — Cost Of Revenue: 21245000000.00
CSCO balance_sheet (annual, 2023-07-31) — Current Assets: 43348000000.00
CSCO balance_sheet (annual, 2023-07-31) — Current Debt: 1733000000.00
CSCO balance_sheet (annual, 2023-07-31) — Current Debt And Capital Lease Obligation: 1733000000.00
CSCO balance_sheet (annual, 2023-07-31) — Current Deferred Liabilities: 13908000000.00
CSCO balance_sheet (annual, 2023-07-31) — Current Deferred Revenue: 13908000000.00
CSCO balance_sheet (annual, 2023-07-31) — Current Liabilities: 31309000000.00
CSCO cash_flow (annual, 2023-07-31) — Deferred Income Tax: -2085000000.00
CSCO cash_flow (annual, 2023-07-31) — Deferred Tax: -2085000000.00
CSCO cash_flow (annual, 2023-07-31) — Depreciation: 1726000000.00
CSCO cash_flow (annual, 2023-07-31) — Depreciation Amortization Depletion: 1726000000.00
CSCO income_statement (annual, 2023-07-31) — Depreciation Amortization Depletion Income Statement: 282000000.00
CSCO cash_flow (annual, 2023-07-31) — Depreciation And Amortization: 1726000000.00
CSCO income_statement (annual, 2023-07-31) — Depreciation And Amortization In Income Statement: 282000000.00
CSCO income_statement (annual, 2023-07-31) — Diluted Average Shares: 4105000000.00
CSCO income_statement (annual, 2023-07-31) — Diluted EPS: 3.07
CSCO income_statement (annual, 2023-07-31) — Diluted NI Availto Com Stockholders: 12613000000.00
CSCO income_statement (annual, 2023-07-31) — EBIT: 15745000000.00
CSCO income_statement (annual, 2023-07-31) — EBITDA: 17471000000.00
CSCO cash_flow (annual, 2023-07-31) — Effect Of Exchange Rate Changes: -105000000.00
CSCO cash_flow (annual, 2023-07-31) — End Cash Position: 11627000000.00
CSCO cash_flow (annual, 2023-07-31) — Financing Cash Flow: -11626000000.00
CSCO balance_sheet (annual, 2023-07-31) — Finished Goods: 1493000000.00
CSCO cash_flow (annual, 2023-07-31) — Free Cash Flow: 19037000000.00
CSCO cash_flow (annual, 2023-07-31) — Gain Loss On Sale Of Business: 206000000.00
CSCO income_statement (annual, 2023-07-31) — Gain On Sale Of Security: -177000000.00
CSCO balance_sheet (annual, 2023-07-31) — Gains Losses Not Affecting Retained Earnings: -1575000000.00
CSCO income_statement (annual, 2023-07-31) — General And Administrative Expense: 2478000000.00
CSCO balance_sheet (annual, 2023-07-31) — Goodwill: 38535000000.00
CSCO balance_sheet (annual, 2023-07-31) — Goodwill And Other Intangible Assets: 40353000000.00
CSCO balance_sheet (annual, 2023-07-31) — Gross Accounts Receivable: 5939000000.00
CSCO balance_sheet (annual, 2023-07-31) — Gross PPE: 10058000000.00
CSCO income_statement (annual, 2023-07-31) — Gross Profit: 35753000000.00
CSCO cash_flow (annual, 2023-07-31) — Income Tax Paid Supplemental Data: 3571000000.00
CSCO balance_sheet (annual, 2023-07-31) — Income Tax Payable: 4235000000.00
CSCO income_statement (annual, 2023-07-31) — Interest Expense: 427000000.00
CSCO income_statement (annual, 2023-07-31) — Interest Expense Non Operating: 427000000.00
CSCO income_statement (annual, 2023-07-31) — Interest Income: 962000000.00
CSCO income_statement (annual, 2023-07-31) — Interest Income Non Operating: 962000000.00
CSCO cash_flow (annual, 2023-07-31) — Interest Paid Supplemental Data: 376000000.00
CSCO balance_sheet (annual, 2023-07-31) — Inventory: 3644000000.00
CSCO balance_sheet (annual, 2023-07-31) — Invested Capital: 52744000000.00
CSCO cash_flow (annual, 2023-07-31) — Investing Cash Flow: -5107000000.00
CSCO cash_flow (annual, 2023-07-31) — Issuance Of Capital Stock: 700000000.00
CSCO cash_flow (annual, 2023-07-31) — Issuance Of Debt: 0.00
CSCO balance_sheet (annual, 2023-07-31) — Loans Receivable: 2988000000.00
CSCO balance_sheet (annual, 2023-07-31) — Long Term Debt: 6658000000.00
CSCO balance_sheet (annual, 2023-07-31) — Long Term Debt And Capital Lease Obligation: 6658000000.00
CSCO cash_flow (annual, 2023-07-31) — Long Term Debt Issuance: 0.00
CSCO cash_flow (annual, 2023-07-31) — Long Term Debt Payments: -500000000.00
CSCO balance_sheet (annual, 2023-07-31) — Machinery Furniture Equipment: 5694000000.00
CSCO cash_flow (annual, 2023-07-31) — Net Business Purchase And Sale: -301000000.00
CSCO cash_flow (annual, 2023-07-31) — Net Common Stock Issuance: -4190000000.00
CSCO income_statement (annual, 2023-07-31) — Net Income: 12613000000.00
CSCO income_statement (annual, 2023-07-31) — Net Income Common Stockholders: 12613000000.00
CSCO income_statement (annual, 2023-07-31) — Net Income Continuous Operations: 12613000000.00
CSCO income_statement (annual, 2023-07-31) — Net Income From Continuing And Discontinued Operation: 12613000000.00
CSCO income_statement (annual, 2023-07-31) — Net Income From Continuing Operation Net Minority Interest: 12613000000.00
CSCO cash_flow (annual, 2023-07-31) — Net Income From Continuing Operations: 12613000000.00
CSCO income_statement (annual, 2023-07-31) — Net Income Including Noncontrolling Interests: 12613000000.00
CSCO income_statement (annual, 2023-07-31) — Net Interest Income: 535000000.00
CSCO cash_flow (annual, 2023-07-31) — Net Investment Purchase And Sale: -3934000000.00
CSCO cash_flow (annual, 2023-07-31) — Net Issuance Payments Of Debt: -1102000000.00
CSCO cash_flow (annual, 2023-07-31) — Net Long Term Debt Issuance: -500000000.00
CSCO income_statement (annual, 2023-07-31) — Net Non Operating Interest Income Expense: 535000000.00
CSCO cash_flow (annual, 2023-07-31) — Net Other Financing Charges: -32000000.00
CSCO cash_flow (annual, 2023-07-31) — Net Other Investing Changes: -23000000.00
CSCO balance_sheet (annual, 2023-07-31) — Net PPE: 2085000000.00
CSCO cash_flow (annual, 2023-07-31) — Net PPE Purchase And Sale: -849000000.00
CSCO cash_flow (annual, 2023-07-31) — Net Short Term Debt Issuance: -602000000.00
CSCO balance_sheet (annual, 2023-07-31) — Net Tangible Assets: 4000000000.00
CSCO balance_sheet (annual, 2023-07-31) — Non Current Accounts Receivable: 614000000.00
CSCO balance_sheet (annual, 2023-07-31) — Non Current Deferred Assets: 6576000000.00
CSCO balance_sheet (annual, 2023-07-31) — Non Current Deferred Liabilities: 11642000000.00
CSCO balance_sheet (annual, 2023-07-31) — Non Current Deferred Revenue: 11642000000.00
CSCO balance_sheet (annual, 2023-07-31) — Non Current Deferred Taxes Assets: 6576000000.00
CSCO balance_sheet (annual, 2023-07-31) — Non Current Note Receivables: 2869000000.00
CSCO income_statement (annual, 2023-07-31) — Normalized EBITDA: 18179000000.00
CSCO income_statement (annual, 2023-07-31) — Normalized Income: 13195684000.00
CSCO cash_flow (annual, 2023-07-31) — Operating Cash Flow: 19886000000.00
CSCO cash_flow (annual, 2023-07-31) — Operating Gains Losses: 206000000.00
CSCO income_statement (annual, 2023-07-31) — Operating Income: 15562000000.00
CSCO income_statement (annual, 2023-07-31) — Operating Revenue: 56998000000.00
CSCO balance_sheet (annual, 2023-07-31) — Ordinary Shares Number: 4066000000.00
CSCO balance_sheet (annual, 2023-07-31) — Other Current Assets: 4352000000.00
CSCO balance_sheet (annual, 2023-07-31) — Other Current Borrowings: 1733000000.00
CSCO balance_sheet (annual, 2023-07-31) — Other Current Liabilities: 5136000000.00
CSCO balance_sheet (annual, 2023-07-31) — Other Equity Adjustments: -1575000000.00
CSCO income_statement (annual, 2023-07-31) — Other Gand A: 2478000000.00
CSCO income_statement (annual, 2023-07-31) — Other Income Expense: -779000000.00
CSCO balance_sheet (annual, 2023-07-31) — Other Intangible Assets: 1818000000.00
CSCO balance_sheet (annual, 2023-07-31) — Other Inventories: 16000000.00
CSCO balance_sheet (annual, 2023-07-31) — Other Non Current Assets: 6007000000.00
CSCO balance_sheet (annual, 2023-07-31) — Other Non Current Liabilities: 2134000000.00
CSCO income_statement (annual, 2023-07-31) — Other Non Operating Income Expenses: -71000000.00
CSCO balance_sheet (annual, 2023-07-31) — Other Properties: 135000000.00
CSCO balance_sheet (annual, 2023-07-31) — Other Receivables: 364000000.00
CSCO balance_sheet (annual, 2023-07-31) — Other Short Term Investments: 16023000000.00
CSCO balance_sheet (annual, 2023-07-31) — Payables: 6548000000.00
CSCO balance_sheet (annual, 2023-07-31) — Payables And Accrued Expenses: 6548000000.00